• Journal of Korean Society for Atmospheric Environment
• /
• v.4 no.2
• /
• pp.20-27
• /
• 1988

A simple two stage aerosol filter sampler which allows simultaneous and fractional collection of two different-size particles, coarse and fine, was constructed and applied to the collection of Seoul atmospheric particulate for inorganic analysis. The sampler consist of two 47-mm diameter filter holder, a pneumatic pump, and a flowmeter. Filtering rate normally runs around 20$\ell$/min for 8 hrs. Using the sampler, a series of seasonal aerosol samples were collected from June 1986 to March 1988 at Yonsei University campus, Seoul and subsequently analysed for ten environmentally important metals using an atomic absorption spectrometer and an inductively coupled plasma emission spectrometer. The analysed metals are Al, Cd, Cr, Cu, Fe, Mn, Ni, Pb, V, and Zn. The analytical results showed the following order of metal abundance; Al > Fe > Zn > Pb > Mn > Cu > V > Ni > Cr > Cd. Based upon their size distribution pattern, the analyzed matals could be clasified into two groups, those present primarily in coarse particle and those in fine particle. Fe, Al, Mn, V, and Cr belong to the former group while the rest to the latter. Most metal concentration were highest in spring or winter, and lowest in autumn. Statistical analysis showed strong correlations between Al and Fe, Pb and Zn, and Cu and Mn.

• The Journal of Korean Medicine
• /
• v.43 no.3
• /
• pp.79-93
• /
• 2022

Objectives: We investigated the isoflavone contained in SH003 and its fractions, and the effect of these components on the inhibition of breast cancer. Methods: The isoflavones in solvent fractions of SH003 extract were identified by UPLC-MS and its contents were quantified using HPLC analysis. The estrogenic activity of SH003 or fractions was assessed by ERE luciferase assay in estrogen receptor (ER)-positive MCF-7 cells. To test the breast cancer inhibitory effect, the cell viability was measured using an MTT assay. Results: In this study, we demonstrated that SH003 and fractions contain 4 isoflavones which are calycosin-7-β-D-glucoside, formononetin-7-β-D-glucoside, calycosin, and formononetin. Despite containing isoflavones, estrogen-dependent transcription activity was not altered by both SH003 and fractions. On the other hand, SH003 and fractions inhibited the cell viability of breast cancer. In addition, its isoflavone components also showed reduced cell viability in various breast cancer cells. Conclusions: Overall, the phytoestrogen included in SH003 and fractions did not influence the estrogenic activity, emphasizing the safety of SH003 and fractions in breast cancer treatment.

• Archives of Pharmacal Research
• /
• v.18 no.6
• /
• pp.415-422
• /
• 1995

Twenty-four flavones were synthesized with various hydroxyl and/or methoxyl groups on A and B rings. Their antimutagenic properties were evaluated against ben:w(a)pyrene (BaP) and a pool of mutagenic urine concentrate (U) using a modified liquid incubation method of Ames test. The tester strain was Salmonella typhimurium TA98+S9 Mix. The antimutagenic activities were calculated by non linear regression analysis and the doses of flavones (in nmoles) required for a 50% reduction of induced revertants with BaP and U were defined as the inhibition doses (TEX>$ID_{508}{\;}and{\;}ID_{508}$ respectively). Seventeen flavones possessed significant antimutagenic activity against BaP. $ID_{508}$ ranged from 15.1 nmoles (F22) to 1000.6 nmoles (F13). Eighteen f1avones showed significant antimutagenic activity against U. $ID_{50U}$ ranged from 23.5 nmoles (F22) to 354.6 nmoles (F3). The 2',3',4'-trihydroxyflavone (F22, $ID_{508}=15.1$ nmoles, $ID_{50U}=23.5$ nmoles) and the 2',3',4',7-tetrahydroxyflavone (F20, $ID_{508}=37.8$ nmoles; $ID_{50U}=62.3$ nmoles) had antimutagenic activities similar to those of chlorophyllin ($ID_{508}=19.6$ nmoles and $ID_{50U}=44.2$ nmoles) and were evaluated against B(alP 7,8-dihydrodiol-9,10-epoxide. Against this last mutagen, the flavones which included three OH in B ring showed the highest activity and this property seemed independent of the substituent groups on A ring.

• Korean Journal of Clinical Pharmacy
• /
• v.32 no.1
• /
• pp.27-36
• /
• 2022

Background: Medication-related problems (MRPs) frequently occur during the discharge period. Elderly patients, particularly, are at high risk for these problems due to polypharmacy and the use of potentially inappropriate medications. The purpose of this study was to build and implement collaboration between general hospital and community pharmacies to address MRPs among high-risk elderly patients before/after discharge. Methods: This retrospective study was conducted between June and December of 2020. The inclusion criteria were patients with aged ≥65 years; residents of Jeonju; discharged from Jeonbuk National University hospital; either on medication of exceeding 10 medications (or high-risk medications) after hospitalization through the emergency room, or having severe illness. Patients received medication reconciliation and counselling by hospital pharmacists before discharge and home-visit pharmaceutical care as follow-up by community pharmacists after discharge. Results: Twenty-two patients agreed to home-visit pharmaceutical services. Fifteen and 11 patients completed the first and second home-visit pharmaceutical care service, respectively. Forty-two MRPs were identified in 15 patients. The types of high-frequency MRPs were incorrect administration of drug, adverse drug reactions, medication non-compliance, drug-drug interactions, lifestyle modifications, and expired medication disposal. After consultation with the pharmacist, 34 out of 42 MRPs were resolved. Conclusions: Transitional care for high-risk elderly patients before and after discharge was successfully built and implemented through a collaboration between general hospital and community pharmacies. This study suggests that home-visit pharmaceutical services may have positive effects on the safe use of drugs during the transition period; however, additional research is needed to expand on these findings.

• Journal of the Korean Society of Food Culture
• /
• v.24 no.2
• /
• pp.236-243
• /
• 2009

This study was performed to investigate the effects of aluminum sulfate administration on the brain tissues of old rats, when given at different concentrations. The experiment attempted to further ascertain whether aluminum exposure cause Alzheimer's disease. Seventy-five aged Sprague-Dawley rats were divided into five groups; a control group, 2 ppm aluminum sulfate group, 20 ppm aluminum sulfate group, 40 ppm aluminum sulfate group, and 200 ppm aluminum sulfate group, and were kept on the respective diets for 12 weeks. In order to understand the influence of aluminum on the brain, serum aluminum concentrations, phospholipid composition, and catecholamine concentrations were compared between the aluminum-treated groups and the normal group. According to the results, serum aluminum was higher in the aluminum sulfate-treated groups than in the normal group. Within the cortex, catecholamine concentrationes were significantly increased but cerebellum and brainstem tissue were significantly decreased, in the aluminum sulfate-treated groups compared to the normal group. For phospholipid composition, phosphatidyl inositol was significantly increased wherase phosphatidyl choline, phosphatidyl ethanolamine, and phosphatidyl serine were significantly decreased in the aluminum sulfate-treated groups versus the normal group. Based on the data, increased aluminum consumption in experimental animals causes increased serum aluminum levels and catecholamine variation. These phenomena are very similar to conditions of Alzherimer's disease. Therfore, the results of this experiment further suggest that aluminum cause Alzherimer's disease, coinciding with reports that aluminum is a cause of neurofibrilly tangles in the brain.

• Analytical Science and Technology
• /
• v.22 no.1
• /
• pp.35-43
• /
• 2009

The goal of PAT (Process Analytical Technology) is to build quality into products through better understanding and control of manufacturing processes, rather than merely testing the quality of the end product. Pharmaceutical manufacturers are trying to develop and implement new technologies in pharmaceutical production and quality control for real-time measurements of critical product and process parameters. Characterization of manufacturing process through experimental design, for evaluation of the effect of product and process variables, represents an integral part of the PAT framework. However, the publications regarding real PAT application to pharmaceutical process are very limited and the technologies are confidential as well. In this review, the case studies related to PAT are shown with real applications from a pharmaceutical company. Additionally, various applications of PAT on the developing stage are introduced with high analytical technologies for the improvement of quality control on manufacturing process.

• Analytical Science and Technology
• /
• v.21 no.5
• /
• pp.345-363
• /
• 2008

Process analytics has been already widely utilized in a large-scale continuous production line such as petroleum industries for several decades. Although the process analytics has a long history, a concept of "Process Analytical Technology (PAT)" has been rapidly adopted as a new paradigm for the process monitoring in the production process of various industries. In this review, current status and recent developments of PAT in various research bodies have been introduced, including the introduction of various types of analytical instruments, chemometrics tools, and perspectives and future applications of PAT as well as the fundamentals on PAT such as terminology and its historical background.

• Korean Journal of Clinical Pharmacy
• /
• v.33 no.2
• /
• pp.135-142
• /
• 2023

Background: Pharmacists communicate with a variety of healthcare experts to prevent medication errors. Situation-Background-Assessment-Recommendation (SBAR) is a tool used for concise and accurate communication. In 2018, we developed the pharmacy-SBAR (P-SBAR) to deliver pharmacists intervention more quickly and effectively through quality improvement activities. Objectives: This study evaluates the efficacy of P-SBAR on pharmacists' intervention activities before and after the implementation of P-SBAR applications. We assessed the impact of P-SBAR on reducing the burden of intervention work, promoting pharmacists' participation, and enhancing the acceptance rate. Methods: This is a retrospective study of the two groups before and after P-SBAR implementation. All pharmacists' intervention records during two periods (2016-2017 and 2019-2020) were extracted from the data warehouse system at Kyunghee University Hospital at Gangdong, Seoul. The outcome was the number of inpatients and pharmacists who participated in the prescription monitoring activity, the number of interventions, and the physicians' acceptance rate. Results: Although the total number of inpatients decreased (364,753 vs. 348,229), the number of pharmacists who participated in intervention activity increased (monthly mean: 15.8 vs. 18.0, p=0.001). The total number of interventions (2,767 vs. 4,389), the frequency of full acceptance (2,018 vs. 3,710), and the monthly acceptance rate increased significantly (73.8% vs. 83.8%, p<0.001). Conclusion: P-SBAR improved accessibility and convenience by digitalizing the intervention activities performed in an offline environment. Improvement in work burden and acceptance rate using P-SBAR is expected to contribute toward reducing medication errors.

• The Journal of Health Technology Assessment
• /
• v.1 no.1
• /
• pp.22-26
• /
• 2013

Objectives: Balancing benefits and risks through the drug life cycle has been discussed for many decades. The objective of this study was to review the processes and tools currently proposed for benefit-risk assessment of medicinal drugs. It aimed to establish scientific and efficient drug safety management system based on the synthetic analysis of benefit-risk evidence. Methods: We conducted a review of exiting literatures published by regulatory agencies or initiatives. Not only quantitative methodologies but also qualitative method were compared to understand their key characteristics for the benefit and risk assessment of drugs. Results: Recently, benefit-risk assessments have more structured approaches to decision making as part of regulatory science. Regulatory agencies such as European Medicines Agency, FDA have prepared plans to apply benefit-risk assessment to regulatory decision making. Also many initiatives such as IMI (Innovative Medicine Initiative) have conducted research and published reports about benefit-risk assessment. For benefit-risk assessment, four kinds of methods are necessary. Frameworks such as BRAT (Benefit Risk Action Team) framework, PrOACT-URL provide guidance for the whole process of decision-making. Metrics are measurements of risk benefit. The estimation techniques are methods to synthesis and combine evidences from various sources. The utility survey techniques are necessary to explicit preferences of various outcome from stakeholders. Conclusion: There is the lack of widely accepted, validated model for benefit-risk assessment. Nor there is an agreement among academia, industry, and government on methods for the quantitative valuation. It is also limited by available evidence and underlying assumptions. Nevertheless, benefit-risk assessment is fundamental to improve transparency, consistency and predictability for decision making through the structured systematic approaches.

• The Journal of the Institute of Internet, Broadcasting and Communication
• /
• v.24 no.1
• /
• pp.9-16
• /
• 2024

It is difficult to know the efficacy of pills if the pill bag or wrapper is lost after purchasing the pill. Many people do not classify the use of commercial pills when storing them after purchasing and taking them, so the inaccessibility of information on the side effects of pills leads to misuse of pills. Even with existing applications that search and provide information about pills, users have to select the details of the pills themselves. In this paper, we develope a pill recognition application by building a model that learns the formulation and colour of 22,000 photos of pills provided by a Pharmaceutical Information Institution to solve the above situation. We also develope a pill medication management function.